A Study of the Efficacy and Safety of Topiramate in Obese, Type 2 Diabetic Patients Inadequately Controlled on Sulfonylurea Therapy

NCT00231634 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

31

Enrollment

INDUSTRY

Sponsor class

Stopped Program discontinued

Conditions

Obesity
Diabetes Mellitus, Type 2
Diabetes Mellitus, Adult-Onset

Interventions

DRUG: topiramate

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.